An exacerbation of hypercalcemia in subjects with PHP occurred on normalization of serum 25OHD levels following the administration of vitamin D2, probably caused by a further rise in serum 1,25(OH)D levels via increased generation induced by persistently elevated circulating PTH. This evidence concerns the gene PTH and hypercalcemia disease.